![]() |
市場調查報告書
商品編碼
1968515
獸用輸液幫浦市場-全球產業規模、佔有率、趨勢、機會、預測:按類型、最終用戶、地區和競爭格局分類,2021-2031年Veterinary Infusion Pumps Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By End User, By Region & Competition, 2021-2031F |
||||||
全球獸用輸液幫浦市場預計將從 2025 年的 3.1245 億美元成長到 2031 年的 4.7525 億美元,複合年成長率為 7.24%。
這些醫療設備對於向動物精準輸注液體、藥物和營養至關重要,其需求主要受全球寵物數量成長和動物醫療保健支出增加的推動。此外,寵物「人性化」運動也進一步促進了這一成長趨勢,飼主希望為寵物提供更優質的醫療服務,同時,需要持續輸液治療的慢性動物疾病發生率也不斷上升。根據美國寵物用品協會(APPA)預測,到2024年,美國寵物產業的總支出將達到1,520億美元,這表明飼主願意在高品質的照護和先進的輸液管理技術方面投入大量資金。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 3.1245億美元 |
| 市場規模:2031年 | 4.7525億美元 |
| 複合年成長率:2026-2031年 | 7.24% |
| 成長最快的細分市場 | 注射幫浦 |
| 最大的市場 | 北美洲 |
儘管市場條件有利,但仍面臨一個重大障礙:現代靜脈輸液系統購置和維護成本高。小規模獸醫診所往往難以滿足這些資金需求,阻礙了發展中地區和預算有限的診所採用先進技術。因此,儘管對先進醫療服務的需求不斷成長,但小規模醫療機構的資金限制仍然阻礙這些重要醫療設備的廣泛應用。
慢性疾病和與老齡化相關的獸醫問題的日益增多是推動輸液幫浦在動物醫學領域廣泛應用的主要動力。隨著伴侶動物壽命的延長,它們更容易患上腎衰竭、癌症和糖尿病等複雜疾病,這些疾病通常需要精準的液體管理和長期用藥。肥胖會進一步加劇這些健康風險,導致手術次數增加和重症監護需求上升,因此,自動化輸液系統對於確保病患安全至關重要。根據寵物肥胖預防協會於2025年4月發布的《2024年寵物肥胖與營養意見調查》,35%的犬飼主33%的貓飼主表示他們的寵物超重或肥胖,這表明與體重相關的健康問題與對先進治療設備的需求之間存在直接聯繫。
此外,寵物保險覆蓋範圍的擴大和醫療費用支出的成長對於讓更多人能夠負擔得起這些先進的治療至關重要。保險覆蓋使得飼主更容易選擇一些以前被認為過於昂貴的治療,例如持續輸液療法和術後護理。這種轉變體現在保險業的強勁表現上。北美寵物健康保險協會發布的《2025年產業趨勢報告》顯示,到2024年底,北美投保寵物總數將達到703萬隻。此外,英國保險協會(ABI)發布的《2025年報告》指出,上年度寵物保險賠付總額達到創紀錄的12.3億英鎊,這使得獸醫醫院有足夠的財力投資高品質的輸液泵,以滿足用戶對先進醫療標準的需求。
現代獸用輸液系統的實施和維護成本高昂,是限制市場成長的主要障礙。雖然先進的輸液幫浦能夠提供更優的輸液管理和更高的病人安全性,但它們需要大量的初始投資,這對於小規模或獨立動物醫院來說往往難以承受。除了購置成本外,專用耗材、定期校準和技術服務的持續費用也給動物醫院的營運預算帶來了額外的負擔。因此,許多資源有限的機構不得不依賴手動輸液技術或過時的設備,這有效地阻礙了先進技術的應用。
近期產業財務數據顯示獸醫診所面臨財務困境,進一步印證了這種經濟壓力。根據美國獸醫協會(AVMA)統計,2024年每位全職獸醫的平均總收入約為554,982美元,經通膨調整後,這一數字較歷史基準值下降。實際購買力的下降限制了診所用於設施改善的可支配資金。因此,當獸醫院面臨收入成長乏力時,它們被迫推遲或放棄對輸液幫浦等昂貴醫療設備的投資,這直接阻礙了全球市場的整體擴張。
無線連接和物聯網功能的整合正在改變全球獸用輸液幫浦市場,滿足了動物醫療保健機構對營運效率的迫切需求。診所正擴大採用智慧輸液系統,可自動將治療數據與電子健康記錄同步,最大限度地減少人為錯誤,使醫護人員能夠專注於患者照護。這些連網設備支援遠端輸液監控,簡化工作流程,同時確保人手不足的醫療機構的安全。這種向數位化最佳化的轉變得到了產業回饋的支持。根據 Covetrus 於 2024 年 7 月發布的報告《2024 年後獸醫醫療產業值得關注的關鍵趨勢》,超過 80% 的獸醫專業人士表示,他們正在積極優先考慮最佳化臨床技術以減少行政工作量。
同時,在高級住院治療費用飆升的背景下,居家獸醫輸液療法正呈現顯著的擴張趨勢。獸醫醫院正在引入小型攜帶式輸液泵,使飼主主人能夠在舒適的家中為寵物進行長期治療,例如化療和疼痛管理。這種轉變有助於寵物更早出院,並有效彌合了必要醫療通訊協定與經濟可行性之間的差距。這一趨勢的主要目的是減輕寵物飼主的經濟負擔。根據Synchrony公司2024年10月發布的《獸醫專科護理調查》,72%的寵物飼主表示「非常」或「極其」擔心專科獸醫護理的經濟影響,這表明市場對更經濟實惠的門診治療方案的需求日益成長。
The Global Veterinary Infusion Pumps Market is projected to expand from USD 312.45 Million in 2025 to USD 475.25 Million by 2031, reflecting a compound annual growth rate of 7.24%. These medical devices are essential for delivering precise volumes of fluids, medications, and nutrients to animals, with demand largely fueled by the growing global pet population and rising spending on animal healthcare. This upward trajectory is further bolstered by the increasing incidence of chronic animal diseases requiring sustained fluid therapy, alongside the trend of pet humanization that drives owners to seek superior medical treatments. According to the American Pet Products Association, total U.S. pet industry expenditures hit $152 billion in 2024, highlighting the substantial financial commitment owners are willing to make for high-standard care and advanced fluid management technologies.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 312.45 MIllion |
| Market Size 2031 | USD 475.25 MIllion |
| CAGR 2026-2031 | 7.24% |
| Fastest Growing Segment | Syringe Infusion Pump |
| Largest Market | North America |
Despite these favorable conditions, the market confronts a notable obstacle regarding the substantial acquisition and maintenance expenses linked to modern infusion systems. Small-scale veterinary clinics frequently encounter difficulties meeting these capital requirements, which restricts the broad adoption of such advanced technology in developing areas or practices operating with limited budgets. Consequently, while the demand for sophisticated care grows, financial constraints within smaller facilities continue to hinder the universal implementation of these critical medical devices.
Market Driver
The escalating incidence of chronic and age-related veterinary conditions serves as a major driver for the broad implementation of infusion pumps within animal healthcare. As companion animals enjoy longer lifespans, they become more prone to complex ailments such as renal failure, cancer, and diabetes, which often require exact fluid regulation and prolonged medication administration. Obesity further aggravates these health dangers, resulting in increased surgical procedures and critical care needs where automated infusion systems are vital for ensuring patient safety. According to the Association for Pet Obesity Prevention's '2024 Pet Obesity & Nutrition Opinion Survey' released in April 2025, 35% of dog owners and 33% of cat owners reported their pets were overweight or obese, creating a direct link between weight-related health issues and the demand for sophisticated therapeutic equipment.
Furthermore, the broadening of pet insurance coverage and healthcare spending is pivotal in rendering these advanced treatments financially feasible for a wider audience. With the security of insurance, pet owners are more likely to pursue expensive interventions, such as continuous infusion therapies and post-operative care, which were previously deemed too costly. This shift is reflected in the insurance sector's strong performance; the North American Pet Health Insurance Association's 'State of the Industry Report 2025' noted that the total number of insured pets in North America hit 7.03 million by the end of 2024. Additionally, the Association of British Insurers reported in 2025 that total pet insurance payouts reached a record £1.23 billion for the preceding year, empowering veterinary facilities to purchase high-quality infusion pumps to satisfy the elevated care standards expected by insured clients.
Market Challenge
The substantial expenses involved in acquiring and maintaining modern veterinary infusion systems represent a significant hurdle to market growth. Although advanced infusion pumps provide superior fluid delivery and enhanced patient safety, they necessitate a considerable initial capital outlay that is often difficult for smaller or independent veterinary clinics to justify. In addition to the purchase price, these devices require ongoing funding for specialized consumables, routine calibration, and technical servicing, further burdening the operational budgets of veterinary practices. As a result, many facilities with limited financial resources are forced to depend on manual fluid administration techniques or outdated equipment, which effectively impedes the widespread integration of advanced technology.
This economic strain is underscored by recent industry financial data illustrating the fiscal difficulties practices face. According to the American Veterinary Medical Association, the average gross revenue per full-time equivalent veterinarian in 2024 was approximately $554,982, a figure indicating a decline when adjusted for inflation compared to previous benchmarks. This reduction in real purchasing power restricts the discretionary funds available for practice enhancements. Consequently, when veterinary clinics encounter stagnating revenue, they are compelled to delay or forego investments in expensive medical devices such as infusion pumps, which directly hampers the overall expansion of the global market.
Market Trends
The incorporation of wireless connectivity and IoT capabilities is transforming the Global Veterinary Infusion Pumps Market by meeting the critical demand for operational efficiency in veterinary practices. Clinics are increasingly implementing smart infusion systems that automatically sync treatment data with electronic medical records, thereby minimizing manual entry errors and allowing staff to focus on patient care. These connected devices enable remote monitoring of fluid delivery, which ensures safety while streamlining workflows in understaffed facilities. This movement toward digital optimization is supported by industry feedback; according to the 'Top Veterinary Industry Trends to Watch in 2024 and Beyond' report by Covetrus in July 2024, over 80% of veterinary professionals stated they are actively prioritizing the optimization of practice technology to reduce administrative workloads.
Concurrently, the growth of home-based veterinary infusion therapy is becoming a significant trend, driven by the escalating costs of advanced inpatient care. Veterinary facilities are utilizing compact, ambulatory infusion pumps that allow pet owners to administer long-term treatments, such as chemotherapy or pain management, within the comfort of their homes. This transition facilitates earlier patient discharge, effectively bridging the gap between required medical protocols and financial feasibility. This trend primarily addresses economic pressures on pet owners; according to the 'Veterinary Specialty Care Study' by Synchrony in October 2024, 72% of pet parents expressed being very or extremely concerned regarding the financial impact of specialty veterinary care, stimulating market demand for more affordable outpatient delivery solutions.
Report Scope
In this report, the Global Veterinary Infusion Pumps Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Veterinary Infusion Pumps Market.
Global Veterinary Infusion Pumps Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: